Mesoblast Ltd
ASX:MSB
Mesoblast Ltd
Gross Profit
Mesoblast Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mesoblast Ltd
ASX:MSB
|
Gross Profit
-$14.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immutep Ltd
ASX:IMM
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CSL Ltd
ASX:CSL
|
Gross Profit
$7.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Gross Profit
AU$95.4m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Gross Profit
AU$314.4m
|
CAGR 3-Years
362%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mesoblast Ltd's Gross Profit?
Gross Profit
-14.3m
USD
Based on the financial report for Dec 31, 2023, Mesoblast Ltd's Gross Profit amounts to -14.3m USD.
What is Mesoblast Ltd's Gross Profit growth rate?
Gross Profit CAGR 3Y
10%
Over the last year, the Gross Profit growth was 43%. The average annual Gross Profit growth rates for Mesoblast Ltd have been 10% over the past three years .